110 related articles for article (PubMed ID: 7015139)
21. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
Kennecke H; McArthur H; Olivotto IA; Speers C; Bajdik C; Chia SK; Ellard S; Norris B; Hayes M; Barnett J; Gelmon KA
Cancer; 2008 Apr; 112(7):1437-44. PubMed ID: 18286526
[TBL] [Abstract][Full Text] [Related]
22. Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).
Davidson NE; O'Neill AM; Vukov AM; Osborne CK; Martino S; White DR; Abeloff MD
J Clin Oncol; 2005 Sep; 23(25):5973-82. PubMed ID: 16087950
[TBL] [Abstract][Full Text] [Related]
23. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.
Morales L; Canney P; Dyczka J; Rutgers E; Coleman R; Cufer T; Welnicka-Jaskiewicz M; Nortier J; Bogaerts J; Therasse P; Paridaens R; ;
Eur J Cancer; 2007 Jan; 43(2):331-40. PubMed ID: 17134892
[TBL] [Abstract][Full Text] [Related]
24. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
[TBL] [Abstract][Full Text] [Related]
25. Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society.
Ahn SH; Son BH; Kim SW; Kim SI; Jeong J; Ko SS; Han W;
J Clin Oncol; 2007 Jun; 25(17):2360-8. PubMed ID: 17515570
[TBL] [Abstract][Full Text] [Related]
26. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
27. Prolonging tamoxifen therapy for primary breast cancer. Findings from the National Surgical Adjuvant Breast and Bowel Project clinical trial.
Fisher B; Brown A; Wolmark N; Redmond C; Wickerham DL; Wittliff J; Dimitrov N; Legault-Poisson S; Schipper H; Prager D
Ann Intern Med; 1987 May; 106(5):649-54. PubMed ID: 3551710
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant tamoxifen in the management of operable breast cancer: the Scottish Trial. Report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh.
Lancet; 1987 Jul; 2(8552):171-5. PubMed ID: 2885637
[TBL] [Abstract][Full Text] [Related]
29. Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapy.
Fisher B; Redmond CK; Wickerham DL; Rockette HE; Brown A; Allegra J; Bowman D; Plotkin D; Wolter J
Breast Cancer Res Treat; 1983; 3(4):355-64. PubMed ID: 6365208
[TBL] [Abstract][Full Text] [Related]
30. A comparison of two and three years of adjuvant tamoxifen.
Wolmark N; Redmond C; Fisher B
Horm Res; 1989; 32 Suppl 1():166-8. PubMed ID: 2613201
[TBL] [Abstract][Full Text] [Related]
31. Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer.
Fisher B; Fisher ER; Redmond C
J Clin Oncol; 1986 Jun; 4(6):929-41. PubMed ID: 3519883
[TBL] [Abstract][Full Text] [Related]
32. The current status of systemic adjuvant therapy in the management of primary breast cancer.
Fisher B; Wolmark N
Surg Clin North Am; 1981 Dec; 61(6):1347-60. PubMed ID: 7031938
[No Abstract] [Full Text] [Related]
33. Adjuvant tamoxifen and chemotherapy in stage II breast cancer: interim findings from NSABP protocol B-09.
Wolmark N; Fisher B
World J Surg; 1985 Oct; 9(5):750-5. PubMed ID: 3904232
[No Abstract] [Full Text] [Related]
34. Disease-free survival at intervals during and following completion of adjuvant chemotherapy: the NSABP experience from three breast cancer protocols.
Fisher B; Redmond C; Wolmark N; Wieand HS
Cancer; 1981 Sep; 48(6):1273-80. PubMed ID: 7023651
[TBL] [Abstract][Full Text] [Related]
35. Levamisole in primary breast cancer. A controlled study in conjunction with l-phenylalanine mustard.
Kay RG; Mason BH; Stephens EJ; Arthur JF; Hitchcock GC; Trindall PL; Rodgers R; Mullins P
Cancer; 1983 Jun; 51(11):1992-7. PubMed ID: 6340820
[TBL] [Abstract][Full Text] [Related]
36. Tamoxifen prophylaxis.
Lancet; 1986 Feb; 1(8475):263-5. PubMed ID: 2868268
[No Abstract] [Full Text] [Related]
37. L-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.
Fisher B; Carbone P; Economou SG; Frelick R; Glass A; Lerner H; Redmond C; Zelen M; Band P; Katrych DL; Wolmark N; Fisher ER
N Engl J Med; 1975 Jan; 292(3):117-22. PubMed ID: 1105174
[TBL] [Abstract][Full Text] [Related]
38. Royal jelly and its hormonal effects in breast cancer: a literature review.
Aavani F; Rahimi R; Goleij P; Rezaeizadeh H; Bahramsoltani R
Daru; 2024 May; ():. PubMed ID: 38717683
[TBL] [Abstract][Full Text] [Related]
39. Immunolocalization of Cytoplasmic ER in ER-negative Breast Carcinoma as a Potent Favorable Prognostic Predictor.
Ebata A; Suzuki T; Shoji-Harada N; Hamanaka Y; Miyashita M; Iwabuchi E; Takagi K; Miki Y; Tada H; Ishida T
Acta Histochem Cytochem; 2023 Aug; 56(4):59-66. PubMed ID: 37680573
[TBL] [Abstract][Full Text] [Related]
40. Systemic therapy for early-stage breast cancer: learning from the past to build the future.
Agostinetto E; Gligorov J; Piccart M
Nat Rev Clin Oncol; 2022 Dec; 19(12):763-774. PubMed ID: 36253451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
